Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
READER: UNR844 in Presbyopia
NCT04806503Phase 2Terminated
- Sponsor
- Novartis
- Start
- Jun 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of lipoic acid choline ester in presbyopia, sponsored by Novartis. Started Jun 2021; status: terminated.
02
Drugs
lipoic acid choline ester
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT04806503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04806503.